» Articles » PMID: 17317783

Multiple Roles for Neurofibromin in Skeletal Development and Growth

Overview
Journal Hum Mol Genet
Date 2007 Feb 24
PMID 17317783
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder primarily characterized by the formation of neurofibromas, café-au-lait spots and freckling. Skeletal abnormalities such as short stature or bowing/pseudarthrosis of the tibia are relatively common. To investigate the role of the neurofibromin in skeletal development, we crossed Nf1flox mice with Prx1Cre mice to inactivate Nf1 in undifferentiated mesenchymal cells of the developing limbs. Similar to NF1 affected individuals, Nf1(Prx1) mice show bowing of the tibia and diminished growth. Tibial bowing is caused by decreased stability of the cortical bone due to a high degree of porosity, decreased stiffness and reduction in the mineral content as well as hyperosteoidosis. Accordingly, osteoblasts show an increase in proliferation and a decreased ability to differentiate and mineralize in vitro. The reduction in growth is due to lower proliferation rates and a differentiation defect of chondrocytes. Abnormal vascularization of skeletal tissues is likely to contribute to this pathology as it exerts a negative effect on cortical bone stability. Furthermore, Nf1 has an important role in the development of joints, as shown by fusion of the hip joints and other joint abnormalities, which are not observed in neurofibromatosis type I. Thus, neurofibromin has multiple essential roles in skeletal development and growth.

Citing Articles

Impaired MC3T3-E1 osteoblast differentiation triggered by oncogenic HRAS is rescued by the farnesyltransferase inhibitor Tipifarnib.

Andrasch Y, Ireri M, Gander J, Timm A, Chennappan S, Fidan M Sci Rep. 2025; 15(1):6832.

PMID: 40000861 PMC: 11861272. DOI: 10.1038/s41598-025-91592-x.


Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.

Botero V, Tomchik S J Neurodev Disord. 2024; 16(1):49.

PMID: 39217323 PMC: 11365184. DOI: 10.1186/s11689-024-09565-6.


Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings.

Thakur U, Ramachandran S, Mazal A, Cheng J, Le L, Chhabra A Skeletal Radiol. 2024; 54(3):407-422.

PMID: 39105762 DOI: 10.1007/s00256-024-04765-6.


Spatial transcriptomics implicates impaired BMP signaling in NF1 fracture pseudarthrosis in murine and patient tissues.

Rios J, Juan C, Shelton J, Paria N, Oxendine I, Wassell M JCI Insight. 2024; 9(16).

PMID: 38990653 PMC: 11343587. DOI: 10.1172/jci.insight.176802.


Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).

ODonohue A, Li X, Lee L, Vasiljevski E, Little D, Munns C PLoS One. 2024; 19(6):e0304778.

PMID: 38913608 PMC: 11195983. DOI: 10.1371/journal.pone.0304778.